Effect of a Compassion Fatigue Resiliency Program

April 29, 2020 updated by: Tuğba Pehlivan, Koc University Hospital

Effect of a Compassion Fatigue Resiliency Program on Nurses' Professional Quality of Life, Perceived Stress, Resilience: A Randomized Controlled Trial

This study aimed to conduct a short- and long-term Compassion Fatigue Resiliency Program and compare its impact on nurses' professional quality of life, perceived stress and resilience. The research was conducted between January 2017 and January 2019 as a randomized controlled trial. The sample comprised 125 oncology-hematology nurses randomly assigned to a Experimental I (short-term Compassion Fatigue Resiliency Program), Experimental II (long-term Compassion Fatigue Resiliency Program) or control group. Data was collected using Personal Information Form, Professional Quality of Life Scale-IV (ProQOL-IV), Perceived Stress Scale, and Resilience Scale for Adults. Measurements were obtained during pre- and post-test and at three-, six- and twelve-month follow-ups. Research hypotheses were analyzed using multilevel models.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The research was conducted with nurses from the oncology-hematology inpatient services, outpatient chemotherapy units and bone marrow transplant (BMT) units of three private hospitals in Istanbul between January 2017 and January 2019. No sample selection models were applied, and out of 153 nurses working in these services, 125 nurses meeting the inclusion criteria were included in the study. Nurses were randomly assigned to the Experimental I, Experimental II, or control group in order to prevent interaction between the subjects working in the same hospital. Of the nurses, 34 completed the short-term program (Experimental I), 49 completed the long-term (Experimental II), and 42 were assigned to the control group.

Data collection: Data was collected using Personal Information Form, Professional Quality of Life Scale-IV (ProQOL-IV), Perceived Stress Scale, and Resilience Scale for Adults Study procedure This study's principal investigator had participated online in a CFRP, developed by Eric Gentry (Licensed Mental Health Counselor) (2002), and received the certificate, and then conducted the program with the nurses. Meetings were held with each institution's directorate of nursing services to determine the training schedules and content. The schedules were planned in accordance with the hospital administration's preferences and by taking nurses' busy schedules into consideration. Preliminary tests were applied to Experimental I, Experiment II, and the control group before the training. Experimental I received a short-term program (five hours per day for two days, ten hours in total) while Experimental II received a long-term one (five weeks, two hours per week, ten hours in total). No intervention was applied to the control group. After the training, a post-test, and three-, six-, and twelve-month follow-up assessments were conducted for all groups.

Program Compassion Fatigue Resiliency Program The purpose of the program: The purpose of the program is to provide oncology-hematology nurses with knowledge and skills that will increase their level of resilience by helping them recognize compassion fatigue, cope with its consequences and work effectively.

The objectives of the training program

Nurses, who successfully complete the program will be able to:

  • Explain the historical development of compassion fatigue among caregivers,
  • Define the developmental process of compassion fatigue,
  • Specify the risk factors for compassion fatigue,
  • Explain the symptoms of compassion fatigue,
  • Raise awareness about their personal history,
  • Explain the concept of stress and its impact on the body,
  • Apply compassion fatigue resilience skills acquired in the program,
  • Professionally create a self-directed resilience plan. Validity and reliability/Rigour The included scales have been tested for validity and reliability for various settings and countries. The investigators chose three private hospitals in Istanbul, which are considered to be close to each other, such as institution (etc. working conditions) and the sociodemographic and professional characteristics of nurses (etc. age, educational status, clinical experience, willingness to work in oncology, voluntarily career choice) that are known to affect dependent variables. Then, the investigators randomly assigned each hospital to the Experimental I, Experimental II, or control group in order to prevent interaction between the nurses working in the same hospital. Finally, the program was conducted by the principal investigator who had participated online in a CFRP, and received the certificate.

Data analysis: SPSS 25.0 software package was used to analyze data. A chi-square test and one-way ANOVA determined whether the scales and information on demographic characteristics and work environment differed among pre-initiative groups; in other words, to measure homogeneity. Variables found to be statistically significant were included in the model as a correction factor for primary hypotheses. Primary research hypotheses were analyzed using multilevel models (MLM). This analysis method has some advantages over others, such as repeated measures ANOVA.

Study Type

Interventional

Enrollment (Actual)

125

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria

  • Nurses working in inpatient oncology-hematology, outpatient chemotherapy, or BMT unit Exclusion criteria
  • Providing care for pediatric oncology patients
  • Being a nurse manager
  • Not providing direct patient care

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Short-term Compassion Fatigue Resiliency Program
Experimental I received a short-term program (five hours per day for two days, ten hours in total).
Behavioral: Compassion Fatigue Resiliency Program (CFRP)
The purpose of Compassion Fatigue Resiliency Program (CFRP) is to provide oncology-hematology nurses with knowledge and skills that will increase their level of resilience by helping them recognize compassion fatigue, cope with its consequences and work effectively.
Experimental: Long-term Compassion Fatigue Resiliency Program
Experimental II received a long-term program (five weeks, two hours per week, ten hours in total).
Behavioral: Compassion Fatigue Resiliency Program (CFRP)
The purpose of Compassion Fatigue Resiliency Program (CFRP) is to provide oncology-hematology nurses with knowledge and skills that will increase their level of resilience by helping them recognize compassion fatigue, cope with its consequences and work effectively.
No Intervention: Control
No intervention was applied to the control group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Professional Quality of Life Scale-IV (ProQoL), "change" is being assessed.
Time Frame: Change from Baseline up to 1 year

Professional Quality of Life Scale-IV (ProQoL): It is a self-reporting instrument consisting of thirty items and three subscales: Compassion Fatigue (CF), Sompassion Satisfaction (CS), and burnout. The scale has no total score. Each subscale is evaluated separately.

  • Scores above 17 indicate high CF levels while scores below 8 indicate low,
  • Scores below 18 indicate low burnout levels while scores above 27 indicate high
  • Scores above 42 indicate high CS levels while those below 33 indicate low
Change from Baseline up to 1 year
Perceived Stress Scale, "change" is being assessed.
Time Frame: Change from Baseline up to 1 year
Perceived Stress Scale: The lowest possible score is 0 and the highest is 40. A high total score is considered a high level of perceived stress.
Change from Baseline up to 1 year
Resilience Scale for Adults, "change" is being assessed.
Time Frame: Change from Baseline up to 1 year
Resilience Scale for Adults: a lowest possible score of 33 and a highest of 165. A high total score is considered a high level of resilience.
Change from Baseline up to 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Koc University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 8, 2017

Primary Completion (Actual)

January 8, 2019

Study Completion (Actual)

January 8, 2019

Study Registration Dates

First Submitted

April 23, 2020

First Submitted That Met QC Criteria

April 29, 2020

First Posted (Actual)

May 4, 2020

Study Record Updates

Last Update Posted (Actual)

May 4, 2020

Last Update Submitted That Met QC Criteria

April 29, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • TPehlivan

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

No, because hospitals told us, the investigators have to keep secret their nurses individual data.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Compassion Fatigue

Clinical Trials on Compassion Fatigue Resiliency Program (CFRP)

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe